Please visit ourCOVID-19 Resources页面有关冠状病毒大流行期间中风护理的更多信息。

COVID-19

跳到:

For Patients and Community

The Institute for Stroke and Cerebrovascular Disease is working hard to monitor the COVID-19 outbreak and provide the proper information, resources and care to the stroke community we serve. Our top priority is the health and safety of our patients, physicians, and staff.

Please check here frequently for updated information. If you have any questions regarding your stroke care during the COVID-19 crisis, please contactinfo.uthiscd@gmail.com.

Last updated: February 28, 2021

保持知情

COVID-19 is a disease caused by a novel coronavirus, a family of viruses that include everything from the common cold to SARS and MERS. Symptoms of COVID-19 are similar to the flu, and can include fever, cough, diarrhea and fatigue. Please check theWorld Health Organization websitefor more information on COVID-19 and best health practices to ensure the well-being of yourself and others.

Despite the current crisis, please remember that in the case of an emergency you should still call 9-1-1 to assist yourself or a loved one.

一般资源

心理健康资源

Please refer to ourMental Health pagefor more information.

Related Media


Clinical Trials

VAST-Rehab

我们正在寻找中风患者参加VAST-Rehab,提供的临床试验physical, occupational, and speech therapiesover a video conference platform so you or a loved one may have access to rehab from the comfort of your homes.

Eligibility criteria:

  • Men and Women
  • 18岁以上
  • Treated for a stroke at Memorial Hermann in the last 6 months (ischemic or hemorrhagic)
  • Recommended to receive rehab services in the home or outpatient facility

有关更多信息,请联系Dorothea“ Dory” Parker713-500-7085或者dorothea.m.parker@uth.tmc.edu

@UthealthStroke Graphics(2)

我是aquire

IACQUIRE logo

I-ACQUIRE, a form of婴儿和幼儿康复, is being evaluated (in 2 amounts) compared to typical treatments for infants and toddlers with hemiparesis, such as one hour weekly each of occupational therapy and physical therapy. Both forms of I-ACQUIRE involve therapy 5 days a week for 4 weeks in a row, provided by a therapist trained in I-ACQUIRE – the name of this form of constraint-induced movement therapy (CIMT).

For more information, please contact Melissa Howard at (713) 500-7914 orMelissa.Howard@uth.tmc.edu或查看信息手册这里(also available inSpanish)


For Professionals

Members affiliated with the Institute for Stroke and Cerebrovascular Disease are authoring guidelines and special reports on stroke care in response to the global pandemic. These papers focus on the prevention, care, and treatment of stroke during these times. Many graduates of our training program are also leading efforts to adapt healthcare in response to the pandemic. Some of these papers are selectively listed below.

Publications

  • Decline in Stroke Presentations During COVID-19 Surge, Ken Uchino, MD, stroke graduate (2001 - 2003)
  • Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams, Sunil Sheth, MD
  • Early Lessons From World War COVID: Reinventing Our Stroke Systems of Care, Sunil A. Sheth, Tzu-Ching Wu, Anjail Sharrief, Christy Ankrom, James C. Grotta, Sean I. Savitz
  • 在COVID-19大流行期间保留中风护理:潜在问题和解决方案。妮可·冈萨雷斯神经病学。2020年5月8日:10.1212/wnl.0000000000009713。doi:10.1212/wnl.0000000000009713。
  • Management of acute ischemic stroke in patients with COVID-19 infection: Insights from an international panel.
  • Marc Ribo and Fahmi Al-Senani Am J Emerg Med. 2020 May 11:S0735-6757(20)30356-9. doi: 10.1016/j.ajem.2020.05.018. Online ahead of print.
  • Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel.
    Marc Ribo
  • Int J Stroke. 2020 May 3:1747493020923234. doi: 10.1177/1747493020923234. Online ahead of print.
    PMID:32362244
  • Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology. Nguyen TN, Abdalkader M, Jovin TG, Nogueira RG, Jadhav AP, Haussen DC, Hassan AE, Novakovic R,Sheth SA,Ortega-Gutierrez S,Panagos PD,Cordina SM,Linfante I,Mansour Oy,Malik AM,Narayanan S,Masoud HE,Chou SH,Khatri R,Janardhan V,Yavagal DR,Yavagal DR,Zaidat OO,Greer DM,Greer DM,Liebeskind DS。
Baidu